Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation.
Overview
- Institute for Neurodegenerative Diseases, University of California San Francisco,San Francisco, CA USA
- Department of Neurology, University of California San Francisco,San Francisco, CA USA
- Gladstone Data Science and Biotechnology Institute, The J. David Gladstone Institutes,San Francisco, CA USA
- Quantitative Bioscience Institute, University of California San Francisco,San Francisco, CA USA
- Department of Cellular and Molecular Pharmacology, University of California San Francisco,San Francisco, CA USA
- Bakar Computational Health Sciences Institute, University of California San Francisco,San Francisco, CA USA
- Department of Biochemistry and Biophysics, University of California San Francisco,San Francisco, CA USA
Abstract
Tau aggregation is a hallmark of several neurodegenerative diseases, including Alzheimer’s disease and frontotemporal dementia. There are disease-causing variants of the tau-encoding gene, MAPT, and the presence of tau aggregates is highly correlated with disease progression. However, the molecular mechanisms linking pathological tau to neuronal dysfunction are not well understood. This is in part due to an incomplete understanding of the normal functions of tau in development and aging, and how the associated molecular and cellular processes change in the context of causal disease variants of tau. To address these questions in an unbiased manner, we conducted multi-omic characterization of iPSC-derived neurons harboring the MAPT V337M mutation or MAPT knockdown. RNA-seq, ATAC-seq, and phosphoproteomics revealed that both the V337M mutation and tau knockdown perturbed levels of transcripts and phosphorylation of proteins related to axonogenesis or axon morphology. When we directly measured axonogenesis, we found that both MAPT V337M and MAPT knockdown caused decreased axon length. Surprisingly, we found that neurons with V337M tau had much lower tau phosphorylation than neurons with WT tau. CRISPR-based screens uncovered regulators of tau phosphorylation in neurons and found that factors involved in axonogenesis modified tau phosphorylation in both MAPT WT and MAPT V337M neurons. Intriguingly, the p38 MAPK pathway specifically modified tau phosphorylation in MAPT V337M neurons. We propose that V337M tau perturbs tau phosphorylation and axon morphology pathways that are relevant to the normal function of tau in development, which could contribute to previously reported cognitive changes in preclinical MAPT variant carriers.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
kampmannlab.ucsf.edu/resources
Availability: 1 check, the latest on 30 September 2026: the link answers (HTTP 200)
- 30 September 2026: the link answers (HTTP 200)
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data availability
Data is provided within the manuscript or supplementary information files
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 4 keywords, 6 funders, 90 references.
Cite
This paper
Mohl, G. A., Dixon, G., Marzette, E., McKetney, J., Samelson, A. J., Serras, C. P., Jin, J., Ariqat, N., Keys, A., Chavira, C., Li, A., Boggess, S. C., Swaney, D. L., & Kampmann, M. (2026). Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation. NPJ dementia, 2(1), 24. https://
BibTeX
@article{mohl2026multi,
author = {Mohl, Gregory A. and Dixon, Gary and Marzette, Emily and McKetney, Justin and Samelson, Avi J. and Serras, Carlota Pereda and Jin, Julianne and Ariqat, Nabeela and Keys, Andrea and Chavira, Cristian and Li, Andrew and Boggess, Steven C. and Swaney, Danielle L. and Kampmann, Martin},
title = {{Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation}},
journal = {NPJ dementia},
year = {2026},
month = apr,
volume = {2},
number = {1},
pages = {24},
publisher = {Springer Science+Business Media},
issn = {3005-1940},
doi = {10.1038/
url = {https://
pmid = {42046563},
pmcid = {PMC13110130}
}
RIS
TY - JOUR
AU - Mohl, Gregory A.
AU - Dixon, Gary
AU - Marzette, Emily
AU - McKetney, Justin
AU - Samelson, Avi J.
AU - Serras, Carlota Pereda
AU - Jin, Julianne
AU - Ariqat, Nabeela
AU - Keys, Andrea
AU - Chavira, Cristian
AU - Li, Andrew
AU - Boggess, Steven C.
AU - Swaney, Danielle L.
AU - Kampmann, Martin
TI - Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation
T2 - NPJ dementia
J2 - NPJ Dement
PY - 2026
DA - 2026/
VL - 2
IS - 1
SP - 24
SN - 3005-1940
PB - Springer Science+Business Media
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation",
"container-title": "NPJ dementia",
"author": [
{
"family": "Mohl",
"given": "Gregory A."
},
{
"family": "Dixon",
"given": "Gary"
},
{
"family": "Marzette",
"given": "Emily"
},
{
"family": "McKetney",
"given": "Justin"
},
{
"family": "Samelson",
"given": "Avi J."
},
{
"family": "Serras",
"given": "Carlota Pereda"
},
{
"family": "Jin",
"given": "Julianne"
},
{
"family": "Ariqat",
"given": "Nabeela"
},
{
"family": "Keys",
"given": "Andrea"
},
{
"family": "Chavira",
"given": "Cristian"
},
{
"family": "Li",
"given": "Andrew"
},
{
"family": "Boggess",
"given": "Steven C."
},
{
"family": "Swaney",
"given": "Danielle L."
},
{
"family": "Kampmann",
"given": "Martin"
}
],
"container-title-short":
"volume": "2",
"issue": "1",
"page": "24",
"DOI": "10.1038/
"PMID": "42046563",
"PMCID": "PMC13110130",
"ISSN": "3005-1940",
"publisher": "Springer Science+Business Media",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
25
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s40035-021-00270-1
- The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.Journal: Translational neurodegenerationIn common: Alzheimer's / dementia, cellular / molecular, 7 references
- [2] doi:10.1186/s12864-022-08502-y [code]
- The evolution of microtubule associated proteins - a reference proteomic perspective.Journal: BMC genomicsIn common: genetics / omics, cellular / molecular, 6 references
- [3] doi:10.1038/s41380-022-01538-2 [code]
- Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport.Journal: Molecular psychiatryIn common: Alzheimer's / dementia, cellular / molecular, 6 references
- [4] doi:10.1016/j.ymthe.2024.01.033
- Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.Journal: Molecular therapy : the journal of the American Society of Gene TherapyIn common: Alzheimer's / dementia, cellular / molecular, 6 references
- [5] doi:10.1016/j.cell.2021.12.041
- Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.Journal: CellIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references
- [6] doi:10.1101/gr.278576.123 [code]
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a &
lt;i& gt;Drosophila& lt;/ i& gt; knock-in tauopathy model. Journal: Genome researchIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references - [7] doi:10.1007/s00401-026-03018-1
- Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.Journal: Acta neuropathologicaIn common: Alzheimer's / dementia, cellular / molecular, 6 references
- [8] doi:10.1186/s13024-024-00731-x
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.Journal: Molecular neurodegenerationIn common: cellular / molecular, 6 references
- [9] doi:10.1016/j.mcpro.2025.101458 [code]
- Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies.Journal: Molecular & cellular proteomics : MCPIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 5 references
- [10] doi:10.1016/j.celrep.2024.115013
- Development of MAPT S305 mutation human iPSC lines exhibiting elevated 4R tau expression and functional alterations in neurons and astrocytes.Journal: Cell reportsIn common: Alzheimer's / dementia, cellular / molecular, 5 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:2d8f9b49d4c2700d…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w.svg
:target: https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w"><img src="https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
